Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_assertion description "[Measures of expression of the M2 cell markers CD14, CD68, CD163, and CD204, which are elevated in high-grade gliomas, and the neutrophil/myeloid-derived suppressor cell (MDSC) subset marker CD15, which is reduced, provide the best index of glioma grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_assertion evidence source_evidence_literature NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_assertion SIO_000772 23741072 NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_assertion wasDerivedFrom befree-20140225 NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_assertion wasGeneratedBy ECO_0000203 NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP253118.RARPn67hJHBtlD4u3YiPhJLqU3UR8pmE4i3JqWzIf8DpI130_provenance.